Novartis to acquire Myricx Bio in deal worth up to USD1.5bn

Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology

Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer

Alligator Bioscience reports first patient dosed in early-stage breast cancer study

Abbisko Therapeutics and AstraZeneca collaborate to conduct combination clinical trial for NSCLC

Caris Life Sciences introduces Caris Detect multi-cancer early detection blood test

Cumberland Pharmaceuticals sharpens focus on rare disease pipeline with USD100m sale of branded US business to Apotex

SciBase submits FDA filing to expand Nevisense use to non‑melanoma skin cancers

Biovica secures Japanese patent for immuno-oncology TKa application

Zelluna awarded NOK16m research grant for Phase 1 cancer study

Anixa Biosciences' breast cancer vaccine technology granted first Korean patent

Nuvation Bio's taletrectinib Marketing Authorisation Application for advanced ROS1-positive non-small cell lung cancer treatment validated in UK

Natera and Aveta Biomics partner on Phase 3 head and neck cancer trial

AstraZeneca's Datroway recommended for EU approval as first-line treatment in metastatic triple-negative breast cancer

Anivive Lifesciences' Laverdia receives FDA approval to treat canine lymphoma